COMMUNIQUÉS West-GlobeNewswire

NEOVACS :2018 Financial Calendar
16/02/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE 2018 Financial Calendar Paris, February 16, 2018, 6pm CET - NEOVACS (Euronext Growth Paris : ALNEV), a leader in active immunotherapies for the treatment of autoimmune [...]
NEOVACS : Agenda financier 2018
16/02/2018
COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE Agenda financier 2018 Paris et Boston, le 16 février 2018, 18h00 CET - NÉOVACS (Euronext Growth Paris : ALNEV), leader de l'immunothérapie active pour [...]
AIT Therapeutics Announces $9.82 Million Private Placement
16/02/2018
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC:AITB), a clinical-stage biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with serious lung [...]
Medtronic Chairman and CEO Omar Ishrak to Speak at CEO Investor Forum 3.0
16/02/2018
DUBLIN - February 16, 2018 - Medtronic plc (NYSE: MDT ), the global leader in medical technology, today announced it will participate in the CECP CEO Investor Forum 3.0 in New York on Monday, February 26, 2018, at 4:00 [...]
Expert Dermatologists Present Latest Information at 2018 AAD Annual Meeting
16/02/2018
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- The 2018 American Academy of Dermatology Annual Meeting will take place from Feb. 16 to 20 at the San Diego Convention Center. The meeting will feature the latest information [...]
BioStem Technologies Inc. Applies for Uplisting to the OTCQX Market
16/02/2018
Pompano Beach, FL, Feb. 16, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem” or the “Company”), a global life sciences corporation, providing innovative technologies with a concentration [...]
Travelan® Revenue Grows Significantly in US and Australia
16/02/2018
Key Highlights: Immuron’s flagship product Travelan® reports revenue in excess of AUS$914K for first 6mths of FY2018 Travelan® US experienced a 250% increase in sales year over year reaching AU$335,000 Travelan® [...]
Arch Biopartners Closes Convertible Note Financing
16/02/2018
TORONTO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX-V: ARCH ) (OTCBB: ACHFF ) announced it has closed the non-brokered, unsecured convertible note (“Note”) financing it [...]
Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors
16/02/2018
CAMBRIDGE, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT ), a leading genome editing company, today announced the appointment of Jessica Hopfield, Ph.D., to its Board of Directors, [...]
Diversicare to Announce Fourth Quarter 2017 Financial Results on Thursday, March 1, 2018
16/02/2018
BRENTWOOD, Tenn., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR ) today announced that it is scheduled to report financial results for its fourth quarter ended December 31, 2017, [...]
NewLink Genetics to Host Its Fourth Quarter and Year End 2017 Financial Results Conference Call on March 1, 2018
16/02/2018
AMES, Iowa, Feb. 16, 2018 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ: NLNK ) today announced that it will release its fourth quarter and year end 2017 financial results on Thursday, March 1, 2018. The [...]
Sientra Launches New miraDry fresh™ Protocol for the miraDry® System at American Academy of Dermatology Annual Meeting
16/02/2018
SANTA BARBARA, Calif., Feb. 16, 2018 (GLOBE NEWSWIRE) -- miraDry, Inc., a subsidiary of Sientra, Inc. (NASDAQ: SIEN ) (“Sientra” or the “Company”), a medical aesthetics company, today announced the launch of a new, [...]
The American Health Council Welcomes Mona Mansour, MD, MS, to its Board of Physicians
16/02/2018
NEW YORK, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Mona Mansour, MD, MS, is welcomed to the Board of Physicians by the American Health Council. Dr. Mansour is currently the Director of Primary Care and School Health in the [...]
Athenex to Present at 2018 RBC Capital Markets Healthcare Conference
16/02/2018
BUFFALO, N.Y., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq: ATNX ), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]
Arcturus Therapeutics Comments on Amended 13D Filing
16/02/2018
SAN DIEGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT ), a leading RNA medicines company, today commented on the amended 13D filing by Joseph E. Payne, who was fired from Arcturus as of [...]
Presence Health Selects R1 RCM for End-to-End Revenue Cycle Management
16/02/2018
CHICAGO, Feb. 16, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM ), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced that Presence Health based [...]
Repligen to Report Fourth Quarter and Full Year 2017 Financial Results
16/02/2018
WALTHAM, Mass., Feb. 16, 2018 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ: RGEN ) today announced that the Company will report fourth quarter and full year 2017 financial results on Thursday, February 22, 2018. The [...]
Cannabis Wheaton Income Corp. Announces New Joint Venture with Peter Quiring - One of Canada’s Largest Greenhouse Builders and Operators to Develop 1.4 Million Square Foot Purpose Built Greenhouse for Cannabis Cultivation
16/02/2018
VANCOUVER, British Columbia, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or "Wheaton" or the " Company ") is pleased to announce that it has [...]
Lexicon Pharmaceuticals to Host Fourth Quarter and Full-Year 2017 Financial Results Conference Call and Webcast on February 22, 2018
16/02/2018
THE WOODLANDS, Texas, Feb. 16, 2018 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX ), will release its fourth quarter and full-year 2017 financial results on Thursday, February 22, 2018 before market [...]

Pages